Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Financial doc
Filing Type

Conflict of Interest

Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.

Should you be removed from our database? Contact us at [email protected]. Read more below.

Samuel Wickline

University of South Florida, Department: Internal Medicine/medicine

Should you be removed from our database? Contact us at [email protected]. Read more below.

Disclosed Conflict of Interest with

AcuPlaq, LLC

Disclosed Value
Listed Reason
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)

NA

Listed Research Project
Prevention and Treatment of Acute Kidney Injury

Acute kidney injury (AKI) is a frequent clinical problem with an increasing incidence, an unacceptably high mortality rate that has not improved in more than 50 years, and no specific treatment. We have recently proposed and evaluated new image based methods for mapping intrarenal blood volume and PO2 with perfluorocarbon nanoparticle contrast agents employing fluorine (19F) imaging and spectroscopy. We will design and deploy new nanoparticle therapeutic agents that are active against selected inflammatory signaling pathways in unique and effective formulations that provide localized sustained release of agents that may be synergistic in early and advanced AKI, and whose effects on kidney cells can be mapped over time with safe, noninvasive imaging tools.

Filed on February 22, 2018.

Tell us what you know about Samuel Wickline's disclosure

We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?

Name Institution Type Company Disclosed Value
Samuel Wickline Washington University Conflict of Interest Acuplaq Inc. $0 - $4,999
Samuel Wickline Washington University Conflict of Interest Entropy Vision, LLC $0 - $4,999
Samuel Wickline Washington University Conflict of Interest Acuplaq, Inc. $0 - $4,999
Samuel Wickline Washington University Conflict of Interest Acuplaq, Inc. Value cannot be readily determined
Samuel Wickline Washington University Conflict of Interest Trasir Therapeutics Value cannot be readily determined
Samuel Wickline Washington University Conflict of Interest Trasir Therapeutics Value cannot be readily determined
Samuel Wickline Washington University Conflict of Interest Acuplaq Inc. Value cannot be readily determined
Samuel Wickline Washington University Conflict of Interest Acuplaq Inc. Value cannot be readily determined
Samuel Wickline Washington University Conflict of Interest Trasir Therapeutics Value cannot be readily determined
Samuel Wickline Washington University Conflict of Interest Trasir Therapeutics Value cannot be readily determined
Samuel Wickline Washington University Conflict of Interest Trasir Therapeutics Value cannot be readily determined
Samuel Wickline Washington University Conflict of Interest Acuplaq, Inc. Value cannot be readily determined
Samuel Wickline Washington University Conflict of Interest Entropy Vision, LLC Value cannot be readily determined
Samuel Wickline University of South Florida Conflict of Interest Trasir Therapeutics Value cannot be readily determined
Samuel Wickline Washington University Conflict of Interest Trasir Therapeutics Value cannot be readily determined
Samuel Wickline University of South Florida Conflict of Interest AcuPlaq, LLC Value cannot be readily determined
Samuel Wickline Washington University Conflict of Interest Trasir Therapeutics Value cannot be readily determined
Samuel Wickline University of South Florida Conflict of Interest Trasir Therapeutics Value cannot be readily determined
If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.
Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page